Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway

Tao Yang,1– 4 Haiqiong Liu,1,3,4 Chaobo Yang,1,3,4 Huaqiang Mo,1,3,4 Xianbao Wang,1,3,4 Xudong Song,1,3,4 Luping Jiang,2 Ping Deng,2 Ran Chen,2 Pengcui Wu,2 Aihua Chen,1,3,4 Jing Yan1,3,4 1Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, P...

Full description

Bibliographic Details
Main Authors: Yang T, Liu H, Yang C, Mo H, Wang X, Song X, Jiang L, Deng P, Chen R, Wu P, Chen A, Yan J
Format: Article
Language:English
Published: Dove Medical Press 2023-08-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/galangin-attenuates-myocardial-ischemic-reperfusion-induced-ferroptosi-peer-reviewed-fulltext-article-DDDT
_version_ 1797739144825274368
author Yang T
Liu H
Yang C
Mo H
Wang X
Song X
Jiang L
Deng P
Chen R
Wu P
Chen A
Yan J
author_facet Yang T
Liu H
Yang C
Mo H
Wang X
Song X
Jiang L
Deng P
Chen R
Wu P
Chen A
Yan J
author_sort Yang T
collection DOAJ
description Tao Yang,1– 4 Haiqiong Liu,1,3,4 Chaobo Yang,1,3,4 Huaqiang Mo,1,3,4 Xianbao Wang,1,3,4 Xudong Song,1,3,4 Luping Jiang,2 Ping Deng,2 Ran Chen,2 Pengcui Wu,2 Aihua Chen,1,3,4 Jing Yan1,3,4 1Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 2Department of Cardiovascular Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, People’s Republic of China; 3Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 4Guangdong Provincial Key Laboratory of Shock and Microcirculation, Southern Medical University, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Jing Yan; Aihua Chen, Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, NO. 253, Gongye Avenue, Guangzhou, 510282, People’s Republic of China, Tel/Fax +86-2061643686, Email yanve1008@126.com; chenaha@126.comPurpose: Myocardial ischemic reperfusion injury (MIRI) is a crucial clinical problem globally. The molecular mechanisms of MIRI need to be fully explored to develop new therapeutic methods. Galangin (Gal), which is a natural flavonoid extracted from Alpinia Officinarum Hance and Propolis, possesses a wide range of pharmacological activities, but its effects on MIRI remain unclear. This study aimed to determine the pharmacological effects of Gal on MIRI.Methods: C57BL/6 mice underwent reperfusion for 3 h after 45 min of ischemia, and neonatal rat cardiomyocytes (NRCs) subjected to hypoxia and reoxygenation (HR) were cultured as in vivo and in vitro models. Echocardiography and TTC-Evans Blue staining were performed to evaluate the myocardial injury. Transmission electron microscope and JC-1 staining were used to validate the mitochondrial function. Additionally, Western blot detected ferroptosis markers, including Gpx4, FTH, and xCT.Results: Gal treatment alleviated cardiac myofibril damage, reduced infarction size, improved cardiac function, and prevented mitochondrial injury in mice with MIRI. Gal significantly alleviated HR-induced cell death and mitigated mitochondrial membrane potential reduction in NRCs. Furthermore, Gal significantly inhibited ferroptosis by preventing iron overload and lipid peroxidation, as well as regulating Gpx4, FTH, and xCT expression levels. Moreover, Gal up-regulated nuclear transcriptive factor Nrf2 in HR-treated NRCs. Nrf2 inhibition by Brusatol abolished the protective effect of Gal against ferroptosis.Conclusion: This study revealed that Gal alleviates myocardial ischemic reperfusion-induced ferroptosis by targeting Nrf2/Gpx4 signaling pathway.Keywords: galangin, ferroptosis, myocardial ischemia/reperfusion injury, Nrf2, Gpx4
first_indexed 2024-03-12T13:53:03Z
format Article
id doaj.art-8b4245e4f5e04ced8bdd1fbc3d1bb8be
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-03-12T13:53:03Z
publishDate 2023-08-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-8b4245e4f5e04ced8bdd1fbc3d1bb8be2023-08-22T20:02:53ZengDove Medical PressDrug Design, Development and Therapy1177-88812023-08-01Volume 172495251186111Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling PathwayYang TLiu HYang CMo HWang XSong XJiang LDeng PChen RWu PChen AYan JTao Yang,1– 4 Haiqiong Liu,1,3,4 Chaobo Yang,1,3,4 Huaqiang Mo,1,3,4 Xianbao Wang,1,3,4 Xudong Song,1,3,4 Luping Jiang,2 Ping Deng,2 Ran Chen,2 Pengcui Wu,2 Aihua Chen,1,3,4 Jing Yan1,3,4 1Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 2Department of Cardiovascular Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, People’s Republic of China; 3Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 4Guangdong Provincial Key Laboratory of Shock and Microcirculation, Southern Medical University, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Jing Yan; Aihua Chen, Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, NO. 253, Gongye Avenue, Guangzhou, 510282, People’s Republic of China, Tel/Fax +86-2061643686, Email yanve1008@126.com; chenaha@126.comPurpose: Myocardial ischemic reperfusion injury (MIRI) is a crucial clinical problem globally. The molecular mechanisms of MIRI need to be fully explored to develop new therapeutic methods. Galangin (Gal), which is a natural flavonoid extracted from Alpinia Officinarum Hance and Propolis, possesses a wide range of pharmacological activities, but its effects on MIRI remain unclear. This study aimed to determine the pharmacological effects of Gal on MIRI.Methods: C57BL/6 mice underwent reperfusion for 3 h after 45 min of ischemia, and neonatal rat cardiomyocytes (NRCs) subjected to hypoxia and reoxygenation (HR) were cultured as in vivo and in vitro models. Echocardiography and TTC-Evans Blue staining were performed to evaluate the myocardial injury. Transmission electron microscope and JC-1 staining were used to validate the mitochondrial function. Additionally, Western blot detected ferroptosis markers, including Gpx4, FTH, and xCT.Results: Gal treatment alleviated cardiac myofibril damage, reduced infarction size, improved cardiac function, and prevented mitochondrial injury in mice with MIRI. Gal significantly alleviated HR-induced cell death and mitigated mitochondrial membrane potential reduction in NRCs. Furthermore, Gal significantly inhibited ferroptosis by preventing iron overload and lipid peroxidation, as well as regulating Gpx4, FTH, and xCT expression levels. Moreover, Gal up-regulated nuclear transcriptive factor Nrf2 in HR-treated NRCs. Nrf2 inhibition by Brusatol abolished the protective effect of Gal against ferroptosis.Conclusion: This study revealed that Gal alleviates myocardial ischemic reperfusion-induced ferroptosis by targeting Nrf2/Gpx4 signaling pathway.Keywords: galangin, ferroptosis, myocardial ischemia/reperfusion injury, Nrf2, Gpx4https://www.dovepress.com/galangin-attenuates-myocardial-ischemic-reperfusion-induced-ferroptosi-peer-reviewed-fulltext-article-DDDTgalanginferroptosismyocardial ischemia/reperfusion injurynrf2gpx4
spellingShingle Yang T
Liu H
Yang C
Mo H
Wang X
Song X
Jiang L
Deng P
Chen R
Wu P
Chen A
Yan J
Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway
Drug Design, Development and Therapy
galangin
ferroptosis
myocardial ischemia/reperfusion injury
nrf2
gpx4
title Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway
title_full Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway
title_fullStr Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway
title_full_unstemmed Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway
title_short Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway
title_sort galangin attenuates myocardial ischemic reperfusion induced ferroptosis by targeting nrf2 gpx4 signaling pathway
topic galangin
ferroptosis
myocardial ischemia/reperfusion injury
nrf2
gpx4
url https://www.dovepress.com/galangin-attenuates-myocardial-ischemic-reperfusion-induced-ferroptosi-peer-reviewed-fulltext-article-DDDT
work_keys_str_mv AT yangt galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT liuh galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT yangc galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT moh galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT wangx galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT songx galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT jiangl galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT dengp galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT chenr galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT wup galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT chena galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway
AT yanj galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway